Yahoo
NSE - Delayed Quote INR

Tarsons Products Limited (TARSONS.NS)

291.00 -12.95 (-4.26%)
At close: October 30 at 3:29:57 PM GMT+5:30
Chart Range Bar
Loading chart for TARSONS.NS
  • Previous Close 303.95
  • Open 303.00
  • Bid --
  • Ask --
  • Day's Range 288.65 - 303.15
  • 52 Week Range 164.45 - 375.00
  • Volume 57,153
  • Avg. Volume 453,029
  • Market Cap (intraday) 15.483B
  • Beta (5Y Monthly) 0.30
  • PE Ratio (TTM) 139.23
  • EPS (TTM) 2.09
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date Sep 20, 2024
  • 1y Target Est --

Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally. The company offers assay plates, biohazard and safetyware, bioprocessing solutions, bottles and carboys, boxes and racks, cell culture ware, centrifuge ware, clamps and stands, clinical and microbiology products, cryoware, desiccators, tubings and connectors, filtration products, general labware, genomics and PCR consumables, laboratory equipment, laboratory utilities, liquid handling consumables, liquid handling reusables, magnetic stirrer bars, PP storage plates, sampling aids, vials and tubes, and volumetric reusables. Its products are used in molecular biology, cell culture, genomics, proteomics, and immunology. Tarsons Products Limited was incorporated in 1983 and is headquartered in Kolkata, India.

www.tarsons.com

1,108

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

TARSONS.NS
24.73%
S&P BSE SENSEX (^BSESN)
12.63%

1-Year Return

TARSONS.NS
0.47%
S&P BSE SENSEX (^BSESN)
11.78%

3-Year Return

TARSONS.NS
38.04%
S&P BSE SENSEX (^BSESN)
16.14%

5-Year Return

TARSONS.NS
57.33%
S&P BSE SENSEX (^BSESN)
25.55%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 1.08B
Earnings --
Profit Margin 0.00%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
200M
400M
600M
800M
1B
0.0%
2.0%
4.0%
6.0%
8.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.51%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    4.41B

  • Net Income Avi to Common (ttm)

    110.95M

  • Diluted EPS (ttm)

    2.09

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    252.56M

  • Total Debt/Equity (mrq)

    61.91%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: